Search clinical trials for: Seasonal vaccine for adolescents

Total 366373 results

University of Leicester
Sanofi Pasteur, a Sanofi Company; University Hospitals, Leicester; World Health... and other collaborators

Completed

Broadening Our Understanding of Early Versus Late Influenza Vaccine Effectiveness (BELIEVE)

Influenza | Influenza -Like Illness

United Kingdom
National Institute of Allergy and Infectious Diseases...
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Completed

Safety of and Immune Response to an H1N1 Influenza Virus Vaccine in HIV Infected Children and Youth

HIV Infections | H1N1 Influenza Virus

United States, Puerto Rico
National Institute of Allergy and Infectious Diseases...
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Completed

Safety of and Immune Response to Two Influenza Vaccines in HIV Infected Children and Adolescents

HIV Infections | Influenza

United States, Puerto Rico
Limited Liability Company Pharm Aid

Completed

Safety and Immunological Efficacy of the Pentavalent Rotavirus Vaccine - Rota-V-Aid™ (Live Attenuated Oral, Freeze-dried) at Healthy Adults Aged 18 to 45 Years.

Rotavirus Infections | Rotavirus Vaccines

Russian Federation
University of Rochester

Completed

Influenza Immunity in Children

Influenza

United States
Janssen Vaccines & Prevention B.V.

Completed

A Study to Evaluate the Safety and Immunogenicity of Seasonal Influenza Vaccine and an Adenovirus Serotype 26- Based Vaccine Encoding for the Respiratory Syncytial Virus Pre-fusion F Protein (Ad26.RSV.preF), With and Without Co-administration, in Adults Aged 60 Years and Older in Stable Health

Healthy

United States
GlaxoSmithKline

Completed

A Study to Evaluate the Reactogenicity, Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Investigational Supra-seasonal Universal Influenza Vaccines - Inactivated (SUIVs) (GSK3816302A) in Healthy Adults Aged 18 to 39 Years

Influenza, Human

United States, Belgium
University of Maryland, Baltimore
D'Antonio Consultants International, Inc.

Completed

Safety Study of Seasonal Influenza Vaccine by Jet Injection

Healthy Adults

United States
ImmunityBio, Inc.

Withdrawn

QUILT-3.050: NANT Colorectal Cancer (CRC) Vaccine: Combination Immunotherapy in Subjects With Recurrent or Metastatic CRC

Colorectal Cancer
Fluart Innovative Vaccine Ltd, Hungary

Completed

Immunogenicity and Tolerability Study of Fluval AB Novo Suspension for Injection for Children and Adolescents

Human Influenza
Novartis Vaccines

Completed

Safety and Immunogenicity of Influenza Vaccine (Surface Antigen, Inactivated) Ph.Eur, Formulation 2010/2011, When Administered to Adult and Elderly Subjects

Seasonal Influenza

Germany
GlaxoSmithKline

Completed

A Study to Investigate the Safety and Immunogenicity of Different Formulations of GSK Biologicals' Meningococcal ACWY Conjugate Vaccine (GSK3536820A and Menveo) Administered to Healthy Adolescents and Young Adults 10 to 40 Years of Age

Meningitis, Meningococcal

Spain, Finland, Estonia, South Africa, Brazil, Mexico, Russian Federation, France, Turkey
University Hospital for Infectious Diseases, Croatia
Sanofi Pasteur, a Sanofi Company

Unknown

Seroprevalence of Pertussis Among Children and Adolescents in Croatia

Immunogenicity, Vaccine

Croatia
National Center for Occupational Health and Infection...
US Department of Veterans Affairs

Terminated

Evaluating Immune Response to Seasonal FluMist in Healthy Adults

Influenza

United States
Children's Mercy Hospital Kansas City
University of Kansas Medical Center; Midwest Cancer Alliance

Completed

High and Low Resource Interventions to Promote HPV Vaccines

Communication | Meningitis, Meningococcal | Satisfaction | Human Papilloma Virus | Tdap - Tetanus, Diphtheria and Acellular Pertussis Vaccination

United States
Ology Bioservices

Completed

Yearly Strain Variation Study, 2010/2011

Influenza | Seasonal Influenza

Austria
Children's Hospital Medical Center, Cincinnati

Completed

Flu Vaccine Study in Neuromuscular Patients 2011

Duchenne Muscular Dystrophy | Spinal Muscular Atrophy | Congenital Muscular Dystrophy
Duke University

Completed

SDH of HPV Vaccine Completion

Human Papilloma Virus

United States
University of Colorado, Denver
National Cancer Institute (NCI); University of California, Los Angeles

Completed

State Immunization Information Systems to Improve HPV Vaccination Rates

HPV Vaccine | Adolescent Health | Vaccine | Immunization | Reproductive Health | Preventive Health Services | Human Papiloma Virus Vaccine | Health Registry

United States
ImmunityBio, Inc.

Unknown

QUILT-3.090: NANT Squamous Cell Carcinoma (SCC) Vaccine: Subjects With SCC Who Have Progressed

Squamous Cell Carcinoma

United States
National Institute of Allergy and Infectious Diseases...

Completed

Co-Administration of AS03 Adjuvanted A/H7N9 IIV With IIV4

Influenza | Influenza Immunisation | Avian Influenza

United States
National Institute of Allergy and Infectious Diseases...
Johns Hopkins Bloomberg School of Public Health; University of Vermont

Completed

Safety and Immunogenicity of the Dengue Virus Vaccine TV005 (TetraVax-DV TV005) in Healthy Adults, Adolescents, and Children in Dhaka, Bangladesh

Dengue

Bangladesh
National Institute of Allergy and Infectious Diseases...

Completed

Two Doses of Multimeric-001 (M-001) Followed by Influenza Vaccine

Influenza | Influenza Immunisation

United States
Novartis Vaccines

Completed

Safety and Immunogenicity of Different Meningitis Vaccine Formulations in Adolescents and Young Adults

Invasive Meningococcal Disease

United States, Poland
Medicago

Completed

Safety, Tolerability and Immunogenicity of a Plant-made Seasonal Quadrivalent VLP Influenza Vaccine in Adults

RNA Virus Infections | Virus Diseases | Respiratory Tract Infections | Respiratory Tract Diseases

United States
University of Florida

Completed

A Multilevel Approach to Increasing HPV Vaccine Initiation Among Adolescents - Part 3

Human Papilloma Virus

United States
Emory University
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Durability and Impact of the Seasonal Influenza Vaccine on H5 Induced B Cell Response (HIPCVAX-010S)

Influenza A Subtype H5N1 Infection

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...
National Cancer Institute (NCI)

Completed

Vaccine Therapy, Cyclophosphamide, and Cetuximab in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer

Pancreatic Cancer

United States
Stanford University
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Genetic and Environmental Factors in the Response to Influenza Vaccination (SLVP028)

Healthy | Influenza

United States
Hvivo

Completed

Characterisation of a New Wild-Type H3N2 Virus for the Human Viral Challenge Model

Influenza
Richard Zimmerman MD
Centers for Disease Control and Prevention

Completed

Immunologic Response to Influenza Vaccination in Children and Adolescents

Immune Response | Influenza, Human

United States
GlaxoSmithKline
University of Surrey

Completed

Post-authorisation Passive Enhanced Safety Surveillance of Seasonal Influenza Vaccines: Pilot Study in England

Influenza, Human

United Kingdom
Medicago

Completed

Immunogenicity, Safety and Tolerability of a Plant-Derived Seasonal Virus-Like-Particle Quadrivalent Influenza Vaccine in Adults

RNA Virus Infections | Virus Diseases | Respiratory Tract Infections | Respiratory Tract Diseases

United States
University of California, Los Angeles
Los Angeles County Department of Public Health

Completed

Increasing Human Papillomavirus Vaccine Uptake in Low-Income, Ethnic Minority Adolescents in Los Angeles County

Human Papilloma Virus Infection

United States
Nova Immunotherapeutics Limited
The Emmes Company, LLC; Nova Laboratories Limited; Mercia Pharma Inc.

Unknown

The Safety, Tolerance, and Immunogenicity of MAS-1-Adjuvanted Seasonal Inactivated Influenza Vaccine (MER4101) (MER4101)

Influenza, Human

United States
Pfizer

Completed

Study to Evaluate the Long-term Antibody Persistence of GlaxoSmithKline (GSK) Biologicals' MenACWY-TT Vaccine (GSK134612) Versus Mencevax ACWY in Healthy Adolescents and Adults and Booster Response to MenACWY-TT Vaccine Administered at 10 Years Post-primary Vaccination

Infections, Meningococcal

Philippines
Takeda

Completed

Immunogenicity and Safety of Tetravalent Dengue Vaccine (TDV) in Adolescents in Non-Endemic Area(s)

Dengue

Mexico
GlaxoSmithKline
Icahn School of Medicine at Mount Sinai

Completed

A Laboratory Evaluation of the Humoral Immune Response in Adults and Children to the H1 Hemagglutinin (HA) Stalk Domain and Other Influenza A Virus Protein Epitopes, After Administration of GlaxoSmithKline (GSK) Biologicals' Pandemic Influenza Vaccines

Immunologic Tests

United States
GlaxoSmithKline

Completed

Study to Assess Seroprevalence of Hepatitis A, Hepatitis B and Bordetella Pertussis in Mexico

Hepatitis A | Viral Hepatitis Vaccines

Mexico
GlaxoSmithKline

Completed

Trial to Assess Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Meningococcal ABCWY Vaccine as Compared to Meningococcal B Vaccine in Adolescents

Infections, Meningococcal

United States, Finland, Poland
Altimmune, Inc.
Optimal Health Research

Completed

Immune Response Following Seasonal Influenza Vaccination

Influenza

United States
Institute of Virology, Vaccines and Sera, Torlak
PATH; World Health Organization; Comac Medical

Completed

Phase 3 Trial of Serbian Seasonal Influenza Vaccine (Torlak-300)

Influenza

Serbia
Dynavax Technologies Corporation

Terminated

Efficacy and Safety Study of TOLAMBA™ in Ragweed-Allergic Adults

Rhinitis, Allergic, Seasonal

United States
Public Health England

Completed

Pertussis and Meningitis C Concomitant Vaccination in Adolescents (Mutliboost)

Pertussis | Meningitis | Immunization | Preventive Immunization; Meningitis

United Kingdom
Novartis Vaccines

Completed

Safety, Tolerability and Immunogenicity of Novartis Meningococcal B Recombinant Vaccine Administered to Healthy Adolescents According to Different Vaccination Schedules

Meningococcal Disease

Chile
Sinovac Biotech Co., Ltd

Completed

Clinical Trial to Evaluate the Safety and Immunogenicity of Quadrivalent Influenza Vaccine (7.5μg/0.25ml)

Seasonal Influenza

China
Sinovac Biotech Co., Ltd

Completed

Clinical Trial to Evaluate the Safety and Immunogenicity of Quadrivalent Influenza Vaccine (15µg/0.5ml)

Seasonal Influenza

China
GlaxoSmithKline
University of Surrey

Completed

Post-authorisation Passive Enhanced Safety Surveillance of Seasonal Influenza Vaccines

Influenza, Human

United Kingdom
Butantan Institute

Completed

Active Surveillance for Adverse Events Following Immunization With the Butantan Trivalent Influenza Vaccine (2018) (FLU-06-IB)

RNA Virus Infections | Virus Diseases | Respiratory Tract Infections | Influenza, Human | Orthomyxoviridae Infections | Physiological Effects of Drugs | Vaccines

Brazil
GlaxoSmithKline

Completed

Safety Study of Herpes Simplex Vaccine in HSV Seronegative and Seropositive Females Between 10 and 17 Years Old

Herpes Simplex

United States, Australia, Spain, Romania, United Kingdom, Belgium, Canada, Estonia, France, Hungary, New Zealand, Sweden, Netherlands, Norway, Greece, Denmark, Iceland, Lithuania

Search clinical trials for: Seasonal vaccine for adolescents

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mozambique

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations